A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Drs Ursula A. Matulonis and Eloise Chapman-Davis discuss overcoming health disparities in endometrial cancer and increasing clinical trial enrollment of Black women.

Uterine cancer is one of the few cancers with increasing mortality; since the mid-2000s the death rate has risen by 1.7% per year. Black women are more likely to die from it. There are more than ...

The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...

Cancer is affecting increasing numbers of young women with the hormone oestrogen thought to play to a central role ...

A coroner found there were "missed opportunities" to treat a 38-year-old woman with cancer. Carla Smith, 38, who died on 7 ...

1Department of Cancer Biology, University of Michigan, Ann Arbor, Michigan. 2Division of Genetic Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.

A CT scan showed signs of advanced endometrial malignancy with "disseminated metastasis". This prompted a report on January biopsy, said the report, which showed "grade one" womb cancer.

IMA-402 is under clinical development by Immatics and currently in Phase II for Uterine Cancer. According to GlobalData, Phase II drugs for Uterine Cancer have a 30% phase transition success rate ...

Compared with chemotherapy alone, the addition of radiation to chemotherapy did not improve overall or recurrence-free survival in patients with locally advanced endometrial cancer, a new phase 3 ...

Endometrial cancer originates in the endometrium ... assessed progression-free survival based on the Response Evaluation Criteria in Solid Tumours v1.1 and OS. At the two-and-a-half-year mark, the ...